EU to Replace Vaccine Export Authorization System With Monitoring Scheme
The European Union will replace its COVID-19 vaccine export controls after they expire on Dec. 31 with a new tool that monitors vaccine shipments, the European Commission said. The current export control mechanism requires would-be exporters to apply for authorization…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
to ship their vaccines outside the EU -- a system that led the union to block some vaccine shipments. The system taking its place is meant to feed the commission "timely, company-specific vaccine export data" and bolster an emphasis on transparency in vaccine exports. The data will be collected by EU member states' customs authorities. “The EU has been at the forefront of the global vaccination effort," EU Trade Commissioner Valdis Dombrovskis said. "We have exported over half our vaccines production and we have supported and funded initiatives such as COVAX, which help to ensure vaccine access to those parts of the world most in need. Mindful of our global responsibilities, I am pleased that we will now replace our current authorisation system with a new monitoring mechanism to get precise data on our exports. There is still important work to be done in the drive to vaccinate the world, therefore we will redouble our efforts on all fronts at the upcoming WTO Ministerial meeting to ensure a holistic global response to the pandemic.” The release said this means that, "as of 1 January 2022, vaccine producers will no longer have to request an authorisation for the export of vaccines outside the EU."